Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Kedudukan dalam Saham #27744
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Harga Saham
$2.15
Modal Pasaran
$30.83M
Perubahan (1 hari)
0.81%
Perubahan (1 tahun)
-61.85%
Negara
KR
Perdagangan IMBdx (461030)

Kategori

Sejarah hasil dividen untuk IMBdx (461030)
Hasil dividen (TTM) bagi IMBdx (simbol saham: 461030) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk IMBdx (461030) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH